{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T20:59:46Z","timestamp":1785358786569,"version":"3.55.0"},"reference-count":78,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.ijbiomac.2025.144311","type":"journal-article","created":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T19:07:34Z","timestamp":1747422454000},"page":"144311","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"P1","title":["Engineering a novel multi-epitope mRNA vaccine against major bacterial meningitis pathogens: E. coli K1, Group B Streptococcus, Listeria monocytogenes, Neisseria meningitidis, and Streptococcus pneumoniae"],"prefix":"10.1016","volume":"317","author":[{"given":"Nasim","family":"Fattahi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeed","family":"Khoshnood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazanin","family":"Omidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Behrooz Sadeghi","family":"Kalani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.ijbiomac.2025.144311_bb0005","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0198772","article-title":"Global etiology of bacterial meningitis: a systematic review and meta-analysis","volume":"13","author":"Oordt-Speets","year":"2018","journal-title":"PLoS One"},{"issue":"21","key":"10.1016\/j.ijbiomac.2025.144311_bb0010","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1056\/NEJMoa1005384","article-title":"Bacterial meningitis in the United States, 1998\u20132007","volume":"364","author":"Thigpen","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.ijbiomac.2025.144311_bb0015","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/S1474-4422(18)30387-9","article-title":"Global, regional, and national burden of meningitis, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"17","author":"Zunt","year":"2018","journal-title":"The Lancet Neurology"},{"issue":"9","key":"10.1016\/j.ijbiomac.2025.144311_bb0020","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.3201\/eid2509.180747","article-title":"Effect of pneumococcal conjugate vaccines on pneumococcal meningitis, England and Wales, July 1, 2000\u2013June 30, 2016","volume":"25","author":"Oligbu","year":"2019","journal-title":"Emerg. Infect. Dis."},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.144311_bb0025","doi-asserted-by":"crossref","first-page":"e744","DOI":"10.1016\/S2214-109X(18)30247-X","article-title":"Burden of Streptococcus pneumoniae and Haemophilus influenzae type b disease in children in the era of conjugate vaccines: global, regional, and national estimates for 2000\u201315","volume":"6","author":"Wahl","year":"2018","journal-title":"Lancet Glob. Health"},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.144311_bb0030","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1097\/WCO.0000000000000934","article-title":"Acute bacterial meningitis","volume":"34","author":"Wall","year":"2021","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.ijbiomac.2025.144311_bb0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2458-13-S3-S21","article-title":"The effect of Haemophilus influenzae type B and pneumococcal conjugate vaccines on childhood meningitis mortality: a systematic review","volume":"13","author":"Davis","year":"2013","journal-title":"BMC Public Health"},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.144311_bb0040","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S1473-3099(14)70027-1","article-title":"Hospital admission rates for meningitis and septicaemia caused by Haemophilus influenzae, Neisseria meningitidis, and Streptococcus pneumoniae in children in England over five decades: a population-based observational study","volume":"14","author":"Martin","year":"2014","journal-title":"Lancet Infect. Dis."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.144311_bb0045","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1086\/649209","article-title":"Changes in Neisseria meningitidis disease epidemiology in the United States, 1998\u20132007: implications for prevention of meningococcal disease","volume":"50","author":"Cohn","year":"2010","journal-title":"Clin. Infect. Dis."},{"issue":"26","key":"10.1016\/j.ijbiomac.2025.144311_bb0050","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.1016\/j.vaccine.2015.12.072","article-title":"Status of vaccine research and development of vaccines for GBS","volume":"34","author":"Heath","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.ijbiomac.2025.144311_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2021.105057","article-title":"An overview of progress from empirical to rational design in modern vaccine development, with an emphasis on computational tools and immunoinformatics approaches","volume":"140","author":"Soleymani","year":"2022","journal-title":"Comput. Biol. Med."},{"key":"10.1016\/j.ijbiomac.2025.144311_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.toxicon.2023.107584","article-title":"Novel toxin-based mRNA vaccine against Clostridium perfringens using in silico approaches","volume":"238","author":"Asadollahi","year":"2024","journal-title":"Toxicon"},{"key":"10.1016\/j.ijbiomac.2025.144311_bb0065","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2023.1291868","article-title":"Designing a polyvalent vaccine targeting multiple strains of varicella zoster virus using integrated bioinformatics approaches","volume":"14","author":"Amin Rani","year":"2023","journal-title":"Front. Microbiol."},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.144311_bb0070","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.00465-24","article-title":"Designing a smallpox B-cell and T-cell multi-epitope subunit vaccine using a comprehensive immunoinformatics approach","volume":"12","author":"Yu","year":"2024","journal-title":"Microbiology spectrum"},{"key":"10.1016\/j.ijbiomac.2025.144311_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.125068","article-title":"Designing a multi-epitopes subunit vaccine against human herpes virus 6A based on molecular dynamics and immune stimulation","volume":"244","author":"Suleman","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"issue":"12","key":"10.1016\/j.ijbiomac.2025.144311_bb0080","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.molmed.2013.09.002","article-title":"Challenges and advances towards the rational design of mRNA vaccines","volume":"19","author":"Pollard","year":"2013","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.ijbiomac.2025.144311_bb0085","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.863234","article-title":"Immunoinformatic design of a multivalent peptide vaccine against mucormycosis: targeting FTR1 protein of major causative fungi","volume":"13","author":"Araf","year":"2022","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.144311_bb0090","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrd.2017.243","article-title":"mRNA vaccines\u2014a new era in vaccinology","volume":"17","author":"Pardi","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.144311_bb0095","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.01151-22","article-title":"Immunoinformatics approach to design novel subunit vaccine against the Epstein-Barr virus","volume":"10","author":"Moin","year":"2022","journal-title":"Microbiology spectrum"},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.144311_bb0100","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.molmed.2019.10.002","article-title":"Tailoring mRNA vaccine to balance innate\/adaptive immune response","volume":"26","author":"Linares-Fern\u00e1ndez","year":"2020","journal-title":"Trends Mol. Med."},{"issue":"11","key":"10.1016\/j.ijbiomac.2025.144311_bb0105","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.4161\/rna.22269","article-title":"Developing mRNA-vaccine technologies","volume":"9","author":"Schlake","year":"2012","journal-title":"RNA Biol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.144311_bb0110","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1586\/14760584.2015.957685","article-title":"The ReNAissanCe of mRNA-based cancer therapy","volume":"14","author":"Van Lint","year":"2015","journal-title":"Expert Rev. Vaccines"},{"issue":"9","key":"10.1016\/j.ijbiomac.2025.144311_bb0115","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1080\/14760584.2017.1355245","article-title":"Mechanism of action of mRNA-based vaccines","volume":"16","author":"Iavarone","year":"2017","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.ijbiomac.2025.144311_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2019.100766","article-title":"Three decades of messenger RNA vaccine development","volume":"28","author":"Verbeke","year":"2019","journal-title":"Nano Today"},{"issue":"10","key":"10.1016\/j.ijbiomac.2025.144311_bb0125","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/nrd4278","article-title":"mRNA-based therapeutics\u2014developing a new class of drugs","volume":"13","author":"Sahin","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.144311_bb0130","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s41392-022-00950-y","article-title":"Advances in COVID-19 mRNA vaccine development","volume":"7","author":"Fang","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"issue":"10432","key":"10.1016\/j.ijbiomac.2025.144311_bb0135","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/S0140-6736(23)02444-3","article-title":"mRNA-based therapeutics: looking beyond COVID-19 vaccines","volume":"403","author":"Parhiz","year":"2024","journal-title":"Lancet"},{"issue":"48","key":"10.1016\/j.ijbiomac.2025.144311_bb0140","doi-asserted-by":"crossref","first-page":"7612","DOI":"10.1016\/j.vaccine.2020.10.016","article-title":"Exploring the out of sight antigens of SARS-CoV-2 to design a candidate multi-epitope vaccine by utilizing immunoinformatics approaches","volume":"38","author":"Safavi","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.ijbiomac.2025.144311_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2022.105793","article-title":"Towards specie-specific ensemble vaccine candidates against mammarenaviruses using optimized structural vaccinology pipeline and molecular modelling approaches","volume":"172","author":"Khan","year":"2022","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.ijbiomac.2025.144311_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2021.105161","article-title":"HantavirusesDB: Vaccinomics and RNA-based therapeutics database for the potentially emerging human respiratory pandemic agents","volume":"160","author":"Khan","year":"2021","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.ijbiomac.2025.144311_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2024.106572","article-title":"Structural vaccinology, molecular simulation and immune simulation approaches to design multi-epitopes vaccine against John Cunningham virus","volume":"189","author":"Suleman","year":"2024","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.ijbiomac.2025.144311_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2024.108056","article-title":"Immunoinformatics-driven in silico vaccine design for Nipah virus (NPV): integrating machine learning and computational epitope prediction","volume":"170","author":"Shahab","year":"2024","journal-title":"Comput. Biol. Med."},{"key":"10.1016\/j.ijbiomac.2025.144311_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2024.106777","article-title":"Structural proteomics guided annotation of vaccine targets and designing of multi-epitopes vaccine to instigate adaptive immune response against Francisella tularensis","volume":"194","author":"Khan","year":"2024","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.ijbiomac.2025.144311_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.126678","article-title":"Immunoinformatics-based potential multi-peptide vaccine designing against Jamestown Canyon Virus (JCV) capable of eliciting cellular and humoral immune responses","volume":"253","author":"Shahab","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2025.144311_bb0175","doi-asserted-by":"crossref","DOI":"10.1177\/11779322241272404","article-title":"Proteomics exploration of Brucella melitensis to design an innovative multi-epitope mRNA vaccine","volume":"18","author":"Asadinezhad","year":"2024","journal-title":"Bioinformatics and Biology Insights"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.144311_bb0180","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbad502","article-title":"Development of innovative multi-epitope mRNA vaccine against Pseudomonas aeruginosa using in silico approaches","volume":"25","author":"Asadinezhad","year":"2024","journal-title":"Brief. Bioinform."},{"key":"10.1016\/j.ijbiomac.2025.144311_bb0185","article-title":"mRNA vaccine design using the proteome of Theileria annulata through immunoinformatics approaches","author":"Fattahi","year":"2025","journal-title":"mSphere"},{"key":"10.1016\/j.ijbiomac.2025.144311_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2021.577785","article-title":"New diagnosis of multiple sclerosis in the setting of mRNA COVID-19 vaccine exposure","volume":"362","author":"Toljan","year":"2022","journal-title":"J. Neuroimmunol."},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.144311_bb0195","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/s41571-024-00902-1","article-title":"Cancer mRNA vaccines: clinical advances and future opportunities","volume":"21","author":"Sayour","year":"2024","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.ijbiomac.2025.144311_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2024.122628","article-title":"mRNA vaccines contribute to innate and adaptive immunity to enhance immune response in vivo","author":"Cao","year":"2024","journal-title":"Biomaterials"},{"issue":"44","key":"10.1016\/j.ijbiomac.2025.144311_bb0205","doi-asserted-by":"crossref","first-page":"30701","DOI":"10.1021\/acsnano.4c09902","article-title":"Spleen-targeted mRNA vaccine doped with manganese adjuvant for robust anticancer immunity in vivo","volume":"18","author":"Luo","year":"2024","journal-title":"ACS Nano"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.144311_bb0210","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/s41541-024-00900-5","article-title":"Distinct dynamics of mRNA LNPs in mice and nonhuman primates revealed by in vivo imaging","volume":"9","author":"Lemdani","year":"2024","journal-title":"npj Vaccines"},{"issue":"11","key":"10.1016\/j.ijbiomac.2025.144311_bb0215","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.it.2021.09.006","article-title":"Host immunity and cellular responses to bacterial outer membrane vesicles","volume":"42","author":"Tiku","year":"2021","journal-title":"Trends Immunol."},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.144311_bb0220","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1111\/mmi.14836","article-title":"Role of internalin proteins in the pathogenesis of Listeria monocytogenes","volume":"116","author":"Ireton","year":"2021","journal-title":"Mol. Microbiol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.144311_bb0225","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s10989-021-10359-w","article-title":"Immunoinformatics insights into the internalin A and B proteins to design a multi-epitope subunit vaccine for L. monocytogenes","volume":"28","author":"Asadollahi","year":"2022","journal-title":"Int. J. Pept. Res. Ther."},{"key":"10.1016\/j.ijbiomac.2025.144311_bb0230","series-title":"Post-genomic Approaches in Drug and Vaccine Development","first-page":"277","article-title":"Outer membrane proteins as potential candidate vaccine targets","author":"Hara","year":"2022"},{"issue":"D1","key":"10.1016\/j.ijbiomac.2025.144311_bb0235","doi-asserted-by":"crossref","first-page":"D204","DOI":"10.1093\/nar\/gku989","article-title":"UniProt: a hub for protein information","volume":"43","author":"Consortium, U","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ijbiomac.2025.144311_bb0240","series-title":"Immunoinformatics: Predicting Immunogenicity In Silico","first-page":"387","article-title":"Prediction methods for B-cell epitopes","author":"Saha","year":"2007"},{"issue":"W1","key":"10.1016\/j.ijbiomac.2025.144311_bb0245","doi-asserted-by":"crossref","first-page":"W502","DOI":"10.1093\/nar\/gkz452","article-title":"IEDB-AR: immune epitope database\u2014analysis resource in 2019","volume":"47","author":"Dhanda","year":"2019","journal-title":"Nucleic Acids Res."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.144311_bb0250","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1145\/2629691","article-title":"NCBI BLASTP on high-performance reconfigurable computing systems","volume":"7","author":"Mahram","year":"2015","journal-title":"ACM Transactions on Reconfigurable Technology and Systems (TRETS)"},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.144311_bb0255","doi-asserted-by":"crossref","first-page":"398","DOI":"10.2174\/1573409915666190318121838","article-title":"VaxiJen dataset of bacterial immunogens: an update","volume":"15","author":"Zaharieva","year":"2019","journal-title":"Curr. Comput. Aided Drug Des."},{"key":"10.1016\/j.ijbiomac.2025.144311_bb0260","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00894-014-2278-5","article-title":"AllerTOP v. 2\u2014a server for in silico prediction of allergens","volume":"20","author":"Dimitrov","year":"2014","journal-title":"J. Mol. Model."},{"key":"10.1016\/j.ijbiomac.2025.144311_bb0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2024.108926","article-title":"ToxinPred 3.0: an improved method for predicting the toxicity of peptides","volume":"179","author":"Rathore","year":"2024","journal-title":"Comput. Biol. Med."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.144311_bb0270","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nprot.2016.169","article-title":"The ClusPro web server for protein\u2013protein docking","volume":"12","author":"Kozakov","year":"2017","journal-title":"Nat. Protoc."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.144311_bb0275","first-page":"82","article-title":"Pymol: an open-source molecular graphics tool","volume":"40","author":"DeLano","year":"2002","journal-title":"CCP4 Newsl. Protein Crystallogr"},{"key":"10.1016\/j.ijbiomac.2025.144311_bb0280","series-title":"The Proteomics Protocols Handbook","author":"Walker","year":"2005"},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.144311_bb0285","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0009862","article-title":"Computational immunology meets bioinformatics: the use of prediction tools for molecular binding in the simulation of the immune system","volume":"5","author":"Rapin","year":"2010","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.144311_bb0290","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1093\/bioinformatics\/16.4.404","article-title":"The PSIPRED protein structure prediction server","volume":"16","author":"McGuffin","year":"2000","journal-title":"Bioinformatics"},{"issue":"suppl_2","key":"10.1016\/j.ijbiomac.2025.144311_bb0295","doi-asserted-by":"crossref","first-page":"W526","DOI":"10.1093\/nar\/gkh468","article-title":"Protein structure prediction and analysis using the Robetta server","volume":"32","author":"Kim","year":"2004","journal-title":"Nucleic Acids Res."},{"issue":"suppl_2","key":"10.1016\/j.ijbiomac.2025.144311_bb0300","doi-asserted-by":"crossref","first-page":"W407","DOI":"10.1093\/nar\/gkm290","article-title":"ProSA-web: interactive web service for the recognition of errors in three-dimensional structures of proteins","volume":"35","author":"Wiederstein","year":"2007","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ijbiomac.2025.144311_bb0305","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2105-9-514","article-title":"ElliPro: a new structure-based tool for the prediction of antibody epitopes","volume":"9","author":"Ponomarenko","year":"2008","journal-title":"BMC Bioinformatics"},{"issue":"W1","key":"10.1016\/j.ijbiomac.2025.144311_bb0310","doi-asserted-by":"crossref","first-page":"W338","DOI":"10.1093\/nar\/gky356","article-title":"CABS-flex 2.0: a web server for fast simulations of flexibility of protein structures","volume":"46","author":"Kuriata","year":"2018","journal-title":"Nucleic Acids Res."},{"issue":"suppl_2","key":"10.1016\/j.ijbiomac.2025.144311_bb0315","doi-asserted-by":"crossref","first-page":"W96","DOI":"10.1093\/nar\/gkh354","article-title":"ClusPro: a fully automated algorithm for protein\u2013protein docking","volume":"32","author":"Comeau","year":"2004","journal-title":"Nucleic Acids Res."},{"issue":"W1","key":"10.1016\/j.ijbiomac.2025.144311_bb0320","doi-asserted-by":"crossref","first-page":"W271","DOI":"10.1093\/nar\/gku339","article-title":"iMODS: internal coordinates normal mode analysis server","volume":"42","author":"L\u00f3pez-Blanco","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ijbiomac.2025.144311_bb0325","series-title":"Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases E-Book: 2-Volume Set","author":"Bennett","year":"2019"},{"issue":"11","key":"10.1016\/j.ijbiomac.2025.144311_bb0330","first-page":"2669","article-title":"Progress toward a group B streptococcal vaccine","volume":"14","author":"Song","year":"2018","journal-title":"Hum. Vaccin. Immunother."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.144311_bb0335","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1001\/jamapediatrics.2018.4826","article-title":"Epidemiology of invasive early-onset and late-onset group B streptococcal disease in the United States, 2006 to 2015: multistate laboratory and population-based surveillance","volume":"173","author":"Nanduri","year":"2019","journal-title":"JAMA Pediatr."},{"key":"10.1016\/j.ijbiomac.2025.144311_bb0340","series-title":"Epidemiology of Meningitis Caused by Neisseria meningitidis, Streptococcus pneumoniae, and Haemophilus influenza","author":"Centers for Disease, C. and Prevention","year":"2012"},{"issue":"8","key":"10.1016\/j.ijbiomac.2025.144311_bb0345","doi-asserted-by":"crossref","first-page":"896","DOI":"10.3390\/vaccines9080896","article-title":"Vaccine design and vaccination strategies against rickettsiae","volume":"9","author":"Osterloh","year":"2021","journal-title":"Vaccines"},{"key":"10.1016\/j.ijbiomac.2025.144311_bb0350","series-title":"Vaccine Design: Methods and Protocols, Volume 1. Vaccines for Human Diseases","first-page":"27","article-title":"Principles in immunology for the design and development of vaccines","author":"Meyer","year":"2022"},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.144311_bb0355","doi-asserted-by":"crossref","first-page":"339","DOI":"10.3390\/vaccines11020339","article-title":"Immunoinformatics approach to design a multi-epitope vaccine against cutaneous leishmaniasis","volume":"11","author":"Naz","year":"2023","journal-title":"Vaccines"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.144311_bb0360","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s12859-023-05183-6","article-title":"Immunoinformatics design of multi-epitope vaccine using OmpA, OmpD and enterotoxin against non-typhoidal salmonellosis","volume":"24","author":"Beikzadeh","year":"2023","journal-title":"BMC bioinformatics"},{"key":"10.1016\/j.ijbiomac.2025.144311_bb0365","doi-asserted-by":"crossref","DOI":"10.1016\/j.health.2022.100044","article-title":"In silico vaccine design: a tutorial in immunoinformatics","volume":"2","author":"Martinelli","year":"2022","journal-title":"Healthcare Analytics"},{"key":"10.1016\/j.ijbiomac.2025.144311_bb0370","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2021.105098","article-title":"Immunoinformatics guided modeling of CCHF_GN728, an mRNA-based universal vaccine against Crimean-Congo hemorrhagic fever virus","volume":"140","author":"Shahrear","year":"2022","journal-title":"Comput. Biol. Med."},{"issue":"14","key":"10.1016\/j.ijbiomac.2025.144311_bb0375","doi-asserted-by":"crossref","first-page":"6363","DOI":"10.1080\/07391102.2021.1883111","article-title":"Exploring the cancer-testis antigen BORIS to design a novel multi-epitope vaccine against breast cancer based on immunoinformatics approaches","volume":"40","author":"Mahdevar","year":"2022","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.ijbiomac.2025.144311_bb0380","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1007\/s10989-018-9780-z","article-title":"In silico analysis of synaptonemal complex protein 1 (SYCP1) and acrosin binding protein (ACRBP) antigens to design novel multiepitope peptide cancer vaccine against breast cancer","volume":"25","author":"Safavi","year":"2019","journal-title":"Int. J. Pept. Res. Ther."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.144311_bb0385","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-01770-w","article-title":"Immunoprotective effect of an in silico designed multiepitope cancer vaccine with BORIS cancer-testis antigen target in a murine mammary carcinoma model","volume":"11","author":"Mahdevar","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijbiomac.2025.144311_bb0390","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.molimm.2019.04.030","article-title":"In silico analysis of transmembrane protein 31 (TMEM31) antigen to design novel multiepitope peptide and DNA cancer vaccines against melanoma","volume":"112","author":"Safavi","year":"2019","journal-title":"Mol. Immunol."}],"updated-by":[{"DOI":"10.1016\/j.ijbiomac.2025.146692","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000}}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025048639?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025048639?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T20:08:08Z","timestamp":1785355688000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813025048639"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":78,"alternative-id":["S0141813025048639"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.144311","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Engineering a novel multi-epitope mRNA vaccine against major bacterial meningitis pathogens: E. coli K1, Group B Streptococcus, Listeria monocytogenes, Neisseria meningitidis, and Streptococcus pneumoniae","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.144311","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"144311"}}